Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow References
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Breithardt, G
Right arrow Articles by Bocker, D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Breithardt, G
Right arrow Articles by Bocker, D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


Cardiac resynchronization therapy into the next decade: from the past to morbidity/mortality trials

G Breithardt1,2, H Kuhn3, D Hammel4, H.-H Scheld4, L Seipel5 and Dirk Bocker1,2

a Department of Cardiology and Angiology, University of Münster, Münster, Germany
b Institute for Arteriosclerosis Research, University of Münster, Münster, Germany
c Department of Internal Medicine and Cardiology, Klinikum Bielefeld, Bielefeld, Germany
d Department of Cardiothoracic Surgery, University of Münster, Münster, Germany
e Department of Cardiology, University of Tübingen, Tübingen, Germany

Abstract

In selected patients, biventricular pacing leads to improvement in left ventricular (LV) performance, especially in the presence of pre-existing marked asynchrony of LV contraction. Improvements are sustained in the great majority of cases, and are accompanied by reduced symptoms, increased walking distance and reduced need for hospitalization. The degree of asynchrony of LV contraction and the amount of myocardial scarring are important parameters that determine the response to cardiac resynchronization therapy (CRT). Improvements in haemodynamics are due not to a positive inotropic effect of pacing but rather to elimination of an unsynchronized energy-wasting contraction pattern. Mortality trials are in progress to assess the effect of CRT on total mortality, arrhythmic mortality and mortality from heart failure.

Key Words: Clinical trials • heart failure • implantable cardioverter-defibrillator therapy • pacing • resynchronization therapy


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Eur J EchocardiogrHome page
S. Ghio, N. Freemantle, A. Serio, G. Magrini, L. Scelsi, M. Pasotti, J. G.F. Cleland, and L. Tavazzi
Baseline echocardiographic characteristics of heart failure patients enrolled in a large European multicentre trial (CArdiac REsynchronisation Heart Failure study)
Eur J Echocardiogr, October 1, 2006; 7(5): 373 - 378.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart J SupplHome page
D Baller, J Vogt, O Lindner, B Lamp, J Holzinger, A Kammeier, P Wielepp, W Burchert, and D Horstkotte
Myocardial oxygen consumption and perfusion before and after cardiac resynchronization therapy: experimental observations and clinical implications
Eur. Heart J. Suppl., August 1, 2004; 6(suppl_D): D91 - D97.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
S. Ghio, C. Constantin, C. Klersy, A. Serio, A. Fontana, C. Campana, and L. Tavazzi
Interventricular and intraventricular dyssynchrony are common in heart failure patients, regardless of QRS duration
Eur. Heart J., April 1, 2004; 25(7): 571 - 578.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.